Yaroslav Ilnytskyy
Overview
Explore the profile of Yaroslav Ilnytskyy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
King S, Schatz N, Babenko O, Ilnytskyy Y, Kovalchuk I, Metz G
Commun Biol
. 2025 Jan;
8(1):38.
PMID: 39794497
Prenatal maternal stress (PNMS) determines lifetime mental and physical health. Here, we show in rats that PNMS has consequences for placental function and fetal brain development across four generations (F0-F3)....
2.
Cherkasova V, Ilnytskyy Y, Kovalchuk O, Kovalchuk I
Int J Mol Sci
. 2024 Apr;
25(8).
PMID: 38674023
Cisplatin and other platinum-derived chemotherapy drugs have been used for the treatment of cancer for a long time and are often combined with other medications. Unfortunately, tumours often develop resistance...
3.
Touahri Y, Hanna J, Tachibana N, Okawa S, Liu H, David L, et al.
Cell Rep
. 2024 Mar;
43(4):114005.
PMID: 38551961
The retina is exquisitely patterned, with neuronal somata positioned at regular intervals to completely sample the visual field. Here, we show that phosphatase and tensin homolog (Pten) controls starburst amacrine...
4.
Rahman A, Yadav N, Byeon B, Ilnytskyy Y, Kovalchuk I
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38474042
Plants are continuously exposed to various environmental stresses. Because they can not escape stress, they have to develop mechanisms of remembering stress exposures somatically and passing it to the progeny....
5.
Cherkasova V, Ilnytskyy Y, Kovalchuk O, Kovalchuk I
Int J Mol Sci
. 2023 Oct;
24(19).
PMID: 37834191
Platinum-derived chemotherapy medications are often combined with other conventional therapies for treating different tumors, including colorectal cancer. However, the development of drug resistance and multiple adverse effects remain common in...
6.
Ilnytskyy Y, Petersen L, McIntyre J, Konno M, DSilva A, Dean M, et al.
Cancer Genomics Proteomics
. 2023 Aug;
20(5):417-432.
PMID: 37643782
Background/aim: Lung cancer remains the main culprit in cancer-related mortality worldwide. Transcript fusions play a critical role in the initiation and progression of multiple cancers. Treatment approaches based on specific...
7.
Fiselier A, Byeon B, Ilnytskyy Y, Kovalchuk O, Kovalchuk I
Epigenomes
. 2022 Oct;
6(4).
PMID: 36278681
Non-coding RNA fragments (ncRFs) are small RNA fragments processed from non-coding RNAs (ncRNAs). ncRFs have various functions and are commonly tissue-specific, and their processing is altered by exposure to stress....
8.
Li D, Ilnytskyy Y, Gojani E, Kovalchuk O, Kovalchuk I
Molecules
. 2022 Sep;
27(18).
PMID: 36144796
is one of the oldest cultivated plants. Many of the medicinal properties of cannabis are known, although very few cannabis-based formulations became prescribed drugs. Previous research demonstrated that cannabis varieties...
9.
Wang B, Li D, Ilnytskyy Y, Kovalchuk I, Kovalchuk O
Cell Death Discov
. 2022 Aug;
8(1):355.
PMID: 35961977
Although we recently demonstrated that miR-34a directly targets tRNA precursors via Argonaute 2 (AGO2)-mediated cleavage, consequently attenuating the proliferation of breast cancer cells, whether tRNA fragments derived from this cleavage...
10.
Fiselier A, Byeon B, Ilnytskyy Y, Kovalchuk I, Kovalchuk O
Epigenomes
. 2022 Apr;
6(2).
PMID: 35466186
Non-coding RNA fragments (ncRFs) are processed from various non-coding RNAs (ncRNAs), with the most abundant being those produced from tRNAs. ncRFs were reported in many animal and plant species. Many...